Annual report
4534.TEDINET S100R7OO
Period2022-04-01 → 2023-03-31
Filed2023-06-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥103.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥110.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥103.0bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥101.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥109.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥8.5bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥14.4bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥9.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥14.8bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥12.3bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.2bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.9bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥9.0bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥14.6bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥6.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥10.6bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥8.6bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.6bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.4bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥6.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥10.6bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥158.8bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥163.1bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥161.8bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥157.5bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥159.0bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.1bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥34.5bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥126.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥128.6bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥127.0bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥120.7bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥125.1bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥47.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥48.4bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥38.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥40.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥41.0bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥37.8bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥35.5bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥7.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥9.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥880m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥6.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥6.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥5.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥178.93 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥277.39 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥222.29 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥117.56 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥212.87 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,470.18 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,424.21 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,317.92 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,113.69 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,189.15 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 79.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.5% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.6% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.2% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.3% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,529 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 1,544 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 1,558 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 1,581 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 1,617 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥95.5bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥102.4bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥95.3bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥94.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥103.0bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥6.4bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥11.4bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥9.0bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥13.5bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥11.6bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.0bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.2bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥8.9bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥13.4bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥7.3bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥10.4bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥9.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.5bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥10.0bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥152.4bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥156.8bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥155.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥148.0bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥152.6bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥27.3bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥30.5bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥125.1bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥126.4bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥124.9bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥118.2bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥122.8bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥42.3bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥42.9bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥195.1 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥274.03 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥232.56 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥114.13 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥252.91 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥80 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥170 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥3,424.59 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,364.03 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,263.57 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,050.75 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,131.12 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 82.1% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.6% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.9% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.5% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 5.8% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.3% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.4% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 38,500,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,160,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,630,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,630,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 20,315,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,252 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 1,280 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 1,298 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 1,298 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 1,323 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 1,488
| Item | Context | Value | Unit |
|---|---|---|---|
| Edinet code | FilingDateInstant | E00947 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45340 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)持田製薬株式会社 | |
| Filer name in english | FilingDateInstant | Mochida Pharmaceutical Co.,Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2023-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2022-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Risk management (text) | FilingDateInstant | Text · Plus | |
| Strategy climate change (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets climate change (text) | FilingDateInstant | Text · Plus | |
| Reference to other information metrics and targets climate change (text) | FilingDateInstant | Text · Plus | |
| Strategy human capital diversity (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets human capital diversity (text) | FilingDateInstant | Text · Plus | |
| Description of metrics related to policy on human resource development and improvement of internal environment and targets and results using such metrics human capital diversity (text) | FilingDateInstant | Text · Plus | |
| Reference to other information metrics and targets human capital diversity (text) | FilingDateInstant | Text · Plus | |
| Reference to other information2 metrics and targets human capital diversity (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus | |
| Major facilities (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |